Quantitative proteomic analysis of human substantia nigra in alzheimer's disease, huntington's disease and multiple sclerosis

Neurochemical Research

Volumn 37, Issue 12, 2012, Pages 2805-2813

  Chen, Sheng ^a   Lu, Frances Fangjia ^a   Seeman, Philip ^b   Liu, Fang ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Huntington's disease; Multiple sclerosis; Quantitative proteomics; Substantia nigra

Indexed keywords

PROTEOME;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNINDEXED SEQUENCE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTEOMICS; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY;

EID: 84871431661     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0874-2     Document Type: Article

References (45)

1. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M (2004) Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4(12):3943-3952
2. Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2(6):420-436
3. Becker J, Craig EA (1994) Heat-shock proteins as molecular chaperones. Eur J Biochem 219(1-2):11-23
4. Blackstock WP, Weir MP (1999) Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol 17(3):121-127
5. Cerione RA (2004) Cdc42: New roads to travel. Trends Cell Biol 14(3):127-132
6. Chen S, Brown IR (2007) Neuronal expression of constitutive heat shock proteins: Implications for neurodegenerative diseases. Cell Stress Chaperones 12(1):51-58
7. Dougherty MK, Morrison DK (2004) Unlocking the code of 14-3-3. J Cell Sci 117(Pt 10):1875-1884
8. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 11(10):1193-1206
9. Gibb WR, Mountjoy CQ, Mann DM, Lees AJ (1989) The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome. J Neurol Neurosurg Psychiatry 52(2): 193-200
10. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17(10):994-999
11. Haber SN, Fudge JL (1997) The primate substantia nigra and VTA: Integrative circuitry and function. Crit Rev Neurobiol 11(4):323-342
12. Hamos JE, Oblas B, Pulaski-Salo D, Welch WJ, Bole DG, Drachman DA (1991) Expression of heat shock proteins in Alzheimer's disease. Neurology 41(3):345-350
13. Kaneko K, Hachiya NS (2006) The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 67(1):169-171
14. Kapogiannis D, Mattson MP (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 10(2):187-198
15. Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ (2010) Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease. Biochim Biophys Acta 1802(7-8):673-681
16. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett 209(1):57-60
17. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 105(11):4441-4446
18. Magrane J, Smith RC, Walsh K, Querfurth HW (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24(7):1700-1706
19. Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med 340(25):1970-1980
20. Meng Y, Liu F, Pang C, Fan S, Song M, Wang D, Li W, Yu S (2011) Label-free quantitative proteomics analysis of cotton leaf response to nitric oxide. J Proteome Res 10(12):5416-5432
21. Moore GRW (1998) Neuropathology and pathophysiology of the multiple sclerosis lesion. In: Paty DW, Ebers GC (eds) Multiple sclerosis. F.A. Davis Company, Philadelphia, pp 257-327
22. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11-22
23. Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K (2008) 14-3-3 zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Neurosci Lett 431(1): 45-50
24. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376-386
25. Ong SE, Pandey A (2001) An evaluation of the use of twodimensional gel electrophoresis in proteomics. Biomol Eng 18(5):195-205
26. Oyanagi K, Takeda S, Takahashi H, Ohama E, Ikuta F (1989) A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol 26(1):13-19
27. Panchaud A, Affolter M, Moreillon P, Kussmann M (2008) Experimental and computational approaches to quantitative proteomics: Status quo and outlook. J Proteomics 71(1):19-33
28. Perez N, Sugar J, Charya S, Johnson G, Merril C, Bierer L, Perl D, Haroutunian V, Wallace W (1991) Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res Mol Brain Res 11(3-4):249-254
29. Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA (2005) Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: A model of Huntington disease. Mol Cell Proteomics 4(12):1849-1861
30. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3(12):1154-1169
31. Schapira AH, Olanow CW (2004) Neuroprotection in Parkinson disease: Mysteries, myths, and misconceptions. JAMA 291(3): 358-364
32. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ (2006) Absolute quantification of proteins by LCMSE: A virtue of parallel MS acquisition. Mol Cell Proteomics 5(1):144-156
33. Tepper JM, Lee CR (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160:189-208
34. Trapp BD, Nave KA (2008) Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269
35. Vissers JP, Langridge JI, Aerts JM (2007) Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 6(5):755-766
36. Walker FO (2007) Huntington's disease. Lancet 369(9557):218-228
37. Walker FO, Raymond LA (2004) Targeting energy metabolism in Huntington's disease. Lancet 364(9431):312-313
38. Walter U, Wagner S, Horowski S, Benecke R, Zettl UK (2009) Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 73(13):1010-1017
39. Washburn MP, Wolters D, Yates JR 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19(3):242-247
40. Werner CJ, Heyny-von Haussen R, Mall G, Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci 6:8
41. Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50(2):169-180
42. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C (2001) Proteolytic 18O labeling for comparative proteomics: Model studies with two serotypes of adenovirus. Anal Chem 73(13): 2836-2842
43. Zhang C, Liu Y, Hu Z, An L, He Y, Hang H (2011) Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses. Protein Cell 2(5):410-422
44. Zhao X, Li Q, Zhao L, Pu X (2007) Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease. Proteomics Clin Appl 1(12):1559-1569
45. Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA (2000) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18(4-5):433-437